Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

Clinical trial NCT00071422 · COMPLETED

Trial details

NCT number: NCT00071422
Sponsor: Exsulin Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2003-10-01
Primary completion: 2004-06-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.